BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11397679)

  • 1. [The clinical use of biological markers of bone turnover in postmenopausal osteoporosis].
    Delmas PD
    Ann Biol Clin (Paris); 2001; 59(3):299-308. PubMed ID: 11397679
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical markers of bone turnover: clinical interpretation in osteoporosis].
    Cormier C; Kindermans C; Souberbielle JC
    Ann Biol Clin (Paris); 2002; 60(3):343-6. PubMed ID: 12050053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical markers of bone remodeling in the prevention of postmenopausal osteoporosis].
    Calleri L; Porcelli A; Surico N
    Minerva Ginecol; 1998 Oct; 50(10):423-8. PubMed ID: 9866953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum beta-CTx(beta-CrossLaps)].
    Okabe R
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():369-72. PubMed ID: 15035154
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemical markers of bone remodeling].
    Briot K; Roux C
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1009-13. PubMed ID: 16316769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy.
    Reginster JY; Collette J; Neuprez A; Zegels B; Deroisy R; Bruyere O
    Bone; 2008 May; 42(5):832-6. PubMed ID: 18316258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of osteoporosis.
    Shepherd AJ
    Altern Ther Health Med; 2004; 10(2):26-33; quiz 34, 92. PubMed ID: 15055091
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004).
    Nishizawa Y; Nakamura T; Ohta H; Kushida K; Gorai I; Shiraki M; Fukunaga M; Hosoi T; Miki T; Chaki O; Ichimura S; Nakatsuka K; Miura M;
    J Bone Miner Metab; 2005; 23(2):97-104. PubMed ID: 15750686
    [No Abstract]   [Full Text] [Related]  

  • 10. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
    Garnero P; Delmas PD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone turnover markers in the management of postmenopausal osteoporosis.
    Brown JP; Albert C; Nassar BA; Adachi JD; Cole D; Davison KS; Dooley KC; Don-Wauchope A; Douville P; Hanley DA; Jamal SA; Josse R; Kaiser S; Krahn J; Krause R; Kremer R; Lepage R; Letendre E; Morin S; Ooi DS; Papaioaonnou A; Ste-Marie LG
    Clin Biochem; 2009 Jul; 42(10-11):929-42. PubMed ID: 19362543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers of bone turnover in osteoporosis.
    Delmas PD; Beaudreuil J
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):31S-36S. PubMed ID: 9273935
    [No Abstract]   [Full Text] [Related]  

  • 14. [Osteoporosis-profile--a bad examination?].
    Sørensen OH; Nielsen SP; Thode J; Eriksen EF
    Ugeskr Laeger; 1994 Sep; 156(38):5503-5. PubMed ID: 7941083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of markers of bone turnover in the assessment of fracture risk in postmenopausal women.
    Delmas PD
    Osteoporos Int; 1998; 8 Suppl 1():S32-6. PubMed ID: 9682795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Outline of Guidelines 2004 for bone marker in osteoporosis].
    Nishizawa Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():37-41. PubMed ID: 18161079
    [No Abstract]   [Full Text] [Related]  

  • 17. [Absolute risk for fracture and WHO guideline. Bone turnover markers as predictive factors for osteoporotic fractures].
    Yoshimura N;
    Clin Calcium; 2007 Jul; 17(7):1049-57. PubMed ID: 17607072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The interest of biochemical markers of bone turnover for monitoring treatment of postmenopausal osteoporosis].
    Kalaï E; Bahlous A; Makdouli A; Sahli H; Klouz A; Lakhal M; Sellami S; Abdelmoula J
    Tunis Med; 2008 Feb; 86(2):122-7. PubMed ID: 18444527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the management of postmenopausal osteoporosis for GPs.
    O'Neill S; MacLennan A; Bass S; Diamond T; Ebeling P; Findlay D; Flicker L; Markwell A; Nowson C; Pocock N; Sambrook P; Singh MF;
    Aust Fam Physician; 2004 Nov; 33(11):910-9. PubMed ID: 15584331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
    Bonnick SL; Shulman L
    Am J Med; 2006 Apr; 119(4 Suppl 1):S25-31. PubMed ID: 16563938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.